ATE106744T1 - Neue methode zur induzierung der ovulation beim menschen. - Google Patents

Neue methode zur induzierung der ovulation beim menschen.

Info

Publication number
ATE106744T1
ATE106744T1 AT90302841T AT90302841T ATE106744T1 AT E106744 T1 ATE106744 T1 AT E106744T1 AT 90302841 T AT90302841 T AT 90302841T AT 90302841 T AT90302841 T AT 90302841T AT E106744 T1 ATE106744 T1 AT E106744T1
Authority
AT
Austria
Prior art keywords
humans
new method
induce ovulation
ovulation
induce
Prior art date
Application number
AT90302841T
Other languages
English (en)
Inventor
Scott C Chappel
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE106744T1 publication Critical patent/ATE106744T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90302841T 1989-03-17 1990-03-16 Neue methode zur induzierung der ovulation beim menschen. ATE106744T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,949 US5087615A (en) 1989-03-17 1989-03-17 Novel method of ovulation induction in humans

Publications (1)

Publication Number Publication Date
ATE106744T1 true ATE106744T1 (de) 1994-06-15

Family

ID=23265819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90302841T ATE106744T1 (de) 1989-03-17 1990-03-16 Neue methode zur induzierung der ovulation beim menschen.

Country Status (10)

Country Link
US (2) US5087615A (de)
EP (1) EP0388223B1 (de)
JP (1) JP2553729B2 (de)
AT (1) ATE106744T1 (de)
CA (1) CA2012170C (de)
DE (1) DE69009548T2 (de)
DK (1) DK0388223T3 (de)
ES (1) ES2054238T3 (de)
HK (1) HK143495A (de)
MX (1) MX9203348A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
AU1575195A (en) * 1994-01-20 1995-08-08 Akzo Nobel N.V. New composition of glycoprotein isoforms having follicle stimulating activity
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
PT1261622E (pt) * 2000-02-22 2007-04-30 Applied Research Systems Lh purificada
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
UA87433C2 (ru) * 2001-10-22 2009-07-27 Еплайд Рісьорч Системз Ерс Холдінг Н.В. Гонадотропины для стимулирования фолликулогенеза
DK1463493T3 (da) * 2001-12-14 2008-02-04 Serono Lab Fremgangsmåder til at inducere æglösning ved anvendelse af en ikke polypeptid-cAMP-niveaumodulator
AU2004226666B9 (en) * 2003-04-02 2010-04-08 Ares Trading S.A. Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
AU2004248931B2 (en) * 2003-06-20 2009-07-16 Ares Trading S.A. Freeze-dried FSH / LH formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
AU601421B2 (en) * 1986-05-02 1990-09-13 Betrola Investments Pty Ltd Method of regulating animal reproduction
CA1317534C (en) * 1987-03-17 1993-05-11 Arthur Newton Ley Method of enumerating escherichia coli
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario

Also Published As

Publication number Publication date
DK0388223T3 (da) 1994-07-04
JP2553729B2 (ja) 1996-11-13
US5087615A (en) 1992-02-11
JPH03246231A (ja) 1991-11-01
ES2054238T3 (es) 1994-08-01
EP0388223A2 (de) 1990-09-19
DE69009548D1 (de) 1994-07-14
CA2012170A1 (en) 1990-09-17
CA2012170C (en) 2000-05-02
US5262518A (en) 1993-11-16
EP0388223A3 (de) 1991-03-06
HK143495A (en) 1995-09-15
MX9203348A (es) 1992-09-01
DE69009548T2 (de) 1994-09-29
EP0388223B1 (de) 1994-06-08

Similar Documents

Publication Publication Date Title
DE68924162D1 (de) Stressproteine und verwendungen dafür.
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
PT76546B (en) Process for preparing functional human urokinase protein
DK597288A (da) Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf
EP0759067A4 (de) Transformierender wachstumsfaktor alpha h1
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DE69009548D1 (de) Neue Methode zur Induzierung der Ovulation beim Menschen.
HUT55801A (en) Process for producing anti-coagulative peptides marked with radioactivity
HU902930D0 (en) Process for producing immunizing peptones as well as pharmaceutical preparatives containing those compounds
DK0393502T3 (da) Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf
YU126690A (sh) Vip-analozi ii
ES2014546A6 (es) Procedimiento para la obtencion de fctor activador de neutrofilos.
EP0252588A3 (de) Verfahren zur Isolierung und Reinigung von P. falciparum CS-Protein in rekombinantem E. coli sowie seine Verwendung als Impfstoff
HUT55800A (en) Process for producing anticoagulant peptides
ATE323724T1 (de) Mpl-liganden analoga
HUT53125A (en) Process for producing peptides with anticoagulant activity
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
DK229984D0 (da) 4-oxothiazolidin-2-yliden-acetamid-derivater
ES2091223T3 (es) Nuevas secuencias de adn que codifican polipeptidos semejantes a ancrod y composiciones que comprenden los productos de expresion de las mismas.
ATA264487A (de) Homogene, rekombinante immun-interferonfragmente
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
FI892769A7 (fi) Menetelmä yhdistelmä-DNA:n inaktivoimiseksi
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
FI871078A7 (fi) Menetelmä ja seos bronkospastisten hengitystietautien hoitamiseksi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time